Tag: Rui Morais

  • Dis-Chem Leadership Succession Ends Saltzman Era

    Dis-Chem co-founder Ivan Saltzman has resigned from the pharmacy retailer’s board after 48 years. His departure ends the founding family’s formal representation in the company’s boardroom. The JSE-listed healthcare group said Saltzman stepped down as a non-executive director with effect from 23 July 2026. He retired as an executive director at the end of June. He then briefly served in…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Dis-Chem CEO Rui Morais Transforms Retail into Healthcare

    When Rui Morais stepped into the leadership role at Dis-Chem in mid-2023, he inherited a retail giant. He took on the task of evolving a founder-led business into a scalable healthcare platform. Now, 1,000 days into the job, Morais’s tenure has seen a significant cultural reset. He has implemented an ambitious integrated healthcare strategy focused on affordability. Morais previously served…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Dis-Chem’s Strategy Towards Healthcare Integration

    Dis-Chem CEO Rui Morais has declared that the pharmacy group’s ongoing transformation is no longer just about Dis-Chem’s strategy or market share, but about its people. While rivals in the consolidating South African pharmacy market bet on scale and diversification, Morais, who took the helm in 2023, believes the company’s most considerable success lies in fundamentally reshaping its internal culture.…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in